Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pegasys + Copegus in liver transplant recipients with recurrent hepatitis C (Nordic study)
2008-006453-40Phase 3Active
- Sponsor
- Karolinska University Hospital
- Start
- Jun 2009
- Modality
- Cytokines & Interferons → Recombinant Proteins and Enzymes, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, DNA Intercalators/Alkylators → Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label, single-arm trial of interferon alfa and ribavirin in hepatitis C virus infection, sponsored by Karolinska University Hospital. Primary endpoint: Sustained virological response (SVR). Started Jun 2009; status: active.
02
Drugs
interferon alfaribavirin
03
Conditions
hepatitis C virus infection
Beyond the preview
Go deeper on 2008-006453-40.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-006453-40.